Clinical trial
Piperacillin/Tazobactam for Bacteremia With Organisms Producing…
NCT00414193 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00414193 |
|---|---|
| Title | Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase |
| Official title | Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Japan Health Sciences Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Bacteremia, AmpC Beta-lactamase |
| Enrollment | 1,000 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2017 |
| Completion | Dec 1, 2017 |
| First posted | Dec 21, 2006 |
| Last update posted | Jun 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: